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A major sialyl-saccharide alditol isolated from mucins of human amniotic fluid was purified by high-perfor- 
mance liquid chromatography followed by high-performance thin-layer chromatography of the methylated 
derivative and subjected to structural analyses which comprised fast atom bombardment and electron im- 
pact-mass pectrometry, methylation analysis, exoglycosidase digestion and CrO, oxidation. The structure 
of a disialylated pentasaccharide characterized by a sialyl-X antigenic determinant was established: 
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1. INTRODUCTION 
Two hybridoma-derived antibodies have been 
recently described which recognize distinct 
epitopes of the sialyl-X or sialyl dimeric X an- 
tigenic determinant as a structural part of 
glycolipids [1,2]. Expression of these car- 
bohydrates with the terminal sequence 
NeuAccu(2-+ 3)Gal,&( 1+~)[Fuw( 1+3)]GlcNAc is 
associated with certain types of human tumors 
[1,3] and shows a similar organ~haracteristi~ 
distribution pattern to that reported for the 
isomeric sialyl-Lea (Ca 19-9) carbohydrate antigen 
[4]. Biosynthesis of both terminal structures may 
be dependent on variant forms of known 
fucosyltransferases with a less restricted substrate 
specificity [S]. 
In normal adult tissue or secretions, car- 
bohydrates with the sialyl-X determinant have 
been characterized chemically as structural com- 
ponents of N-asparaginylglycans in rat brain [a], 
on human granulocytes [7] and of mucus glycopro- 
teins in human seminal plasma [8]. In human 
seminal plasma and in amniotic fluid sialyl-X an- 
tigen is expressed concertedly with the sialyl-Lea 
isomer ([8,9] and unpub~shed). Here, we report on 
the structural characterization of a major hep- 
tasaccharide of human amniotic mucin 
characterized by a sialyl-X antigenic terminus. 
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2. MATERIALS AND METHODS 
2.1. Preparative methods 
Amniotic fluid from individual donors 
(0.5-1.0 1) was obtained from the University 
Clinic of Gynecology and Obstetrics, Cologne, 
FRG. Insoluble material was centrifuged off or 
removed by filtration prior to extraction of the 
clear, yellow liquid with an equal volume of 90% 
aqueous phenol at 65°C for 15 min. Further steps 
of mucin preparation, including gel filtration on 
Sephacryl S400 in phosphate-buffered guanidi- 
nium chloride (4 M), have been described [lo]. 
Reductive P-elimination of bound carbohydrates 
and their chromatographic purification comprising 
ion-exchange chromatography on DEAE-Sephadex 
and high-performance liquid chromatography 
(HPLC) on aminopropyl silicate were performed 
as described (81. Sialyl saccharides of fraction FW4 
(0.1 mg) were solubilized in 0.1 ml acetate (50 
mM), CaClz (9 mM), NaCl(O.15 M), pH 5.5, con- 
taining 0.1 unit of Vibrio cholerae or Clostridium 
perfringens sialidase. After incubation for 1 h at 
37°C the reaction mixture was diluted with water 
(9/l) and applied onto a column of DEAE- 
Sephadex A25 (0.5 x 3 cm). Desialylated sac- 
charides of the run through were purified on 
HPLC and methylated. 
2.2. Analytical methods 
Monosaccharides were analyzed by gas-liquid 
chromatography (GLC) as trimethylsilyl deriva- 
tives of the corresponding methyl glycosides [l 11. 
The oligosaccharide alditols (approx. 0.1 mg) were 
methylated, hydrolyzed, reduced and acetylated 
according to Stellner et al. [12] with minor modifi- 
cations and the resulting mixture of partially 
methylated alditol acetates was analyzed by GLC/ 
mass spectrometry [8]. Prior to direct probe mass 
spectrometry the methylated saccharide alditol in 
fraction FW4 was purified from contaminating 
material on high-performance thin-layer chro- 
matography (HPTLC) using chloroform/benzene/ 
ethanol (2: 2: 1, v/v) for development of the 
plates. Fast atom bombardment-mass pectrom- 
etry (FAB-MS) was performed on a VG analytical 
ZAB-HF reversed-geometry mass spectrometer. 
FAB spectra of underivatized sialyl saccharides 
were recorded in the negative [13], those of the 
permethylated erivatives in the positive ion mode 
[ 14). Conditions for direct-probe electron impact- 
mass spectrometry (EI-MS) have been described 
191. 
3. RESULTS 
Acidic carbohydrates isolated by reductive ,& 
elimination from mucins of human amniotic fluid 
(250 mg) were separated from neutral car- 
bohydrates on DEAE-Sephadex A25 (fraction I 
eluting with 0.1 M pyridine-acetate, 17 mg; frac- 
tion II eluting with 0.5 M pyridine-acetate, 40 mg) 
and fractionated by HPLC on aminopropyl silicate 
columns. Fraction FW 4 (major peak at 63 min), 
representing approx. 6-7% of the acidic car- 
bohydrates in fraction II, was methylated and fur- 
ther purified on HPTLC. The major component of 
fraction FW 4 was finally subjected to structural 
analyses in FAB- and EI-MS. 
According to the pseudo-molecular ion M + Na+ 
in FAB-MS at m/z 1879 (fig.la) and the known 
mass increments of deoxyhexose, hexose or N- 
acetylhexosamine residues, in conjunction with 
results of a monosaccharide analysis the saccharide 
alditol is composed of ZV-acetylneuramic acid 
(NeuAc) [2], galactose [2], N-acetylglucosamine 
[ 11, L-fucose [l] and ZV-acetylgalactosaminitol 
(GalNAc-01) [ 11. The combined FAB- and EI- 
derived fragmentation pathways for the saccharide 
alditols were used to substantiate the carbohydrate 
sequence and linkage pattern of terminal residues. 
In FAB and EI-MS a terminal di- and a tetrasac- 
charide unit gave rise to formation of ions at m/z 
580 and m/z 999, respectively, which may indicate 
the structures of two branches NeuAc-Hex and 
NeuAc-Hex-[dHex-]HexNAc, where Hex denotes 
hexose and dHex represents deoxyhexose. 
From the intense secondary ion at m/z 793 in 
FAB-MS which originates from the primary frag- 
ment at m/z 999 through elimination of a deox- 
yhexose residue, it may be concluded that deox- 
yhexose is linked to C3 of the subterminal 
N-acetylhexosamine in the NeuAc-Hex-[dHex-]- 
HexNAc branch. This conclusion is based on well- 
documented evidence [ 15,161. 
A minor component comigrating with the hep- 
tasaccharide alditol gives rise to M + Na+: 2154; 
its composition corresponds to NeuAcz-Hex3- 
HexNAcz-HexNAc-OH. Because the contami- 
nating octasaccharide does not contain a deoxy- 
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Fig.1. FAB mass spectrum of permethylated FW4 component registered in the positive ion mode. Fragment ions 
observed only in the EI-MS are shown in parentheses (a); FAB mass spectrum of methylated FW4 component after 
treatment with K cholerue sialidase and fractionation on DEAE-Sephadex A25 (b). 
hexose residue, the ion m/z 825 which represents a
NeuAc-Hex-HexNAc-sequence can be attributed 
to this component. The ion at m/z 811 probably 
does not result from undermethylation of the car- 
bohydrate fragment NeuAc-Hex-HexNAc re- 
presented at m/z 825. Its abundant appearance in 
common with a secondary ion at m/z 793 more 
likely supports the assumption that both ions are 
derived from the fragment at m/z 999 through suc- 
cessive elimination of (dHex-H20) or (dHex), 
respectively. 
The branching pattern of the heptasaccharide 
alditol becomes evident from the complete absence 
of m/z 276 in both EI- and FAB-MS, indicating a 
doubly substituted hexosaminitol residue. In addi- 
tion, a fragment at m/z 783 in EI-MS (not shown) 
suggests that the N-acetylneuraminic acid-hexose 
unit is linked to C3 of the N-acetylgalactosaminitol 
residue. Methylation analysis corroborated the 
presence of 3,6-di-O-substituted N-acetylgalacto- 
saminitol in the FW4 component. Moreover, par- 
tially methylated alditol acetates were detected and 
identified in capillary GLC-MS which point to the 
presence of 3,Cdi-O-substituted N-acetylglucos- 
44 
Volume 200, number 1 FEBS LETTERS May 1986 
amine and 3-O-substituted galactose. After treat- 
ment of fraction FW4 with I’. choferae sialidase 
the asialo derivative of the major component could 
be separated from the minor (enzyme-resistant) oc- 
tasaccharide on DEAE-Sephadex A25. FAB-MS 
of the permethylated compound yielded M + Na+: 
1157 (fig.lb). As expected, the trisaccharide ion 
Hex( 1 +4)[dHex( 1 + 3)]HexNAc represented by 
m/z 638 gave rise to intense daughter ions at m/z 
450 and 432, again indicating a l-r3 linkage of the 
fucose residue to the N-acetylglucosamine. 
The anomeric configuration of the glycosidic 
bonds was established on the basis of ex- 
oglycosidase digestion and CrO3 oxidation. On 
digestion with sialidases from I/. cholerae or C. 
perfringens the disialylated saccharide alditol is 
quantitatively converted into the corresponding 
asialo derivative as judged from the HPLC profile 
after treatment and FAB-MS analysis of the reac- 
tion products (flg.lb). Both N-acetylneuraminic 
acid residues are presumed to be cu-glycosidically 
linked to the subterminal sugar. L-Fucose was not 
accessible to digestion by the a-L-fucosidase from 
bovine kidney. The cu-anomeric onfiguration of 
fucose became evident on CrO3 oxidation of the 
acetylated sugar since 90% of the deoxyhexose was 
resistant to the oxidative treatment. On the other 
hand, galactose and N-acetylglucosamine were 
destroyed quantitatively under the same condi- 
tions, suggesting that these residues have the ,& 
configuration. 
4. DISCUSSION 
Although most of the monoclonal antibody 
defined, tumor-associated carbohydrate antigens 
belong to the class of glycolipids [ 171, evidence has 
been obtained for mucins representing the relevant 
antigens in the diagnosis of cancer in patients’ sera 
[ 181. However, the immunochemical detection of 
these aberrant carbohydrate epitopes on mucins of 
normal body fluids and their structural 
characterization in this and in previous contribu- 
tions [8,9] pose two questions. (i) Are there any 
structural differences between the mucin oligosac- 
charides of normal body fluids and their counter- 
parts in cancer sera, which are not readily detect- 
able by means of monoclonal antibodies with 
glycolipid-epitopes? (ii) Are the same postulated 
variants of known glycosyltransferases involved in 
the biosynthesis of aberrant carbohydrate struc- 
tures both on mucins shed by the tumor cell and 
those secreted into normal body fluids? Therefore, 
work is in progress aimed at the production of 
monoclonal antibodies with mucin epitopes, which 
recognize the sialyl-X and sialyl-Le” antigenic 
determinants. Moreover, the ready availability of 
the source may enable us to isolate partially a rare- 
ly expressed a-3-L-fucosyltransferase from am- 
niotic fluid, which is involved in sialyl-X 
biosynthesis. 
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